Fiera Capital (Canada)
SUPN icon

Fiera Capital (Canada)’s Supernus Pharmaceuticals SUPN Stock Holding History

Fiera Capital (Canada)’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-817,982
Closed -$27.1M – 683
2019
Q2 		$27.1M Sell
817,982
-57,098
-7% -$1.96M 0.1% 147
2019
Q1 		$30.7M Sell
875,080
-66,450
-7% -$2.47M 0.12% 138
2018
Q4 		$31.3M Buy
941,530
+53,404
+6% +$2.3M 0.14% 124
2018
Q3 		$44.7M Sell
888,126
-37,283
-4% -$1.84M 0.18% 109
2018
Q2 		$55.4M Sell
925,409
-10,436
-1% -$541K 0.24% 87
2018
Q1 		$42.9M Sell
935,845
-50,188
-5% -$2.09M 0.2% 93
2017
Q4 		$39.3M Sell
986,033
-58,639
-6% -$2.32M 0.19% 107
2017
Q3 		$41.8M Buy
1,044,672
+136,029
+15% +$5.89M 0.2% 102
2017
Q2 		$39.2M Sell
908,643
-87,719
-9% -$3.12M 0.19% 100
2017
Q1 		$31.2M Sell
996,362
-95,849
-9% -$2.57M 0.16% 136
2016
Q4 		$27.6M Sell
1,092,211
-220,431
-17% -$4.93M 0.15% 152
2016
Q3 		$32.5M Sell
1,312,642
-39,520
-3% -$894K 0.18% 135
2016
Q2 		$27.5M Buy
+1,352,162
New +$24M 0.15% 159

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Fiera Capital (Canada)'s SUPN Position: Q3 2019 in Review

Fiera Capital (Canada) sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 817,982 shares — an estimated $27.1M sold.

Fiera Capital (Canada) first reported a position in SUPN in Q2 2016 and held it in 13 quarters. The position peaked at $55.4M in Q2 2018. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

  • Fiera Capital (Canada) reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Fiera Capital (Canada) sold 817,982 Supernus Pharmaceuticals shares in Q3 2019, an estimated $27.1M.
  • Fiera Capital (Canada) first reported a position in Supernus Pharmaceuticals in Q2 2016 and held it in 13 quarters.
  • Fiera Capital (Canada)'s Supernus Pharmaceuticals position peaked at $55.4M in Q2 2018.
  • 243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2019, filed 12 Nov 2019.